“InterChem” developed and brought to market a new form of the drug “Gidazepam ІC®” – sublingual tablets

Now “Gidazepam IC®” is available in two medicinal forms: oral and sublingual. A preparation effect is shown in 5-15 minutes after receiving a single sublingual dose, and after receiving the oral form – in 30-60 minutes. The maximum effect is reached within 1-4 hours, followed by gradual weakening.

Sublingual form of benzodiazepines are used to control anxiety and prevention of emotional stress, such as for patients before surgery and dental procedures. Such well-known drugs like lorazepam, zolpidem, clonazepam are available in sublingual form.

Sublingual form of the drug “Gidazepam IC®” allows to accelerate onset of action of the drug, which is especially valuable in urgent situations – before surgery and diagnostic procedures (eg, endoscopic examination), and also allows to use the drug in an environment where oral administration is impossible or difficult – lack of drinking water, difficulty swallowing.

“Gidazepam IC®” belongs to the group of benzodiazepines. It has action of “daytime” tranquilizer and selective anxiolytic. “Gidazepam IC®” has an original range of pharmacological activity, combining the anxiolytic and activating action with the antidepressant components. The maximum effect is reached within 1-4 hours, followed by gradual weakening.

Indications for use:

– neurotic, psychopathic asthenia;

– conditions accompanied by anxiety, fear (including fear of painful surgery and diagnostic examinations), increased irritability, sleep disorders;

– emotional lability;

– relief of withdrawal symptoms of alcoholism;

– supportive therapy during remission in chronic alcoholism;

– logoneurosis, migraine.